JUVA LIFE INC.
Juva Life Inc. acquires, owns, and operates in cannabis business in medical and recreational cannabis sectors in California, the United States. The company operates through two segments, The Resale of Merchandise and Cannabis-Derived Products and Cultivation and Sale of Trim and Flowers. Juva Life Inc. was founded in 2018 and is based in Vancouver, Canada.
JUVA LIFE INC. (4VV) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, JUVA LIFE INC. (4VV) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
JUVA LIFE INC. - Net Assets Trend (None–None)
This chart illustrates how JUVA LIFE INC.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for JUVA LIFE INC. (None–None)
The table below shows the annual net assets of JUVA LIFE INC. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to JUVA LIFE INC.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
JUVA LIFE INC. Competitors by Market Cap
The table below lists competitors of JUVA LIFE INC. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Scandium International Mining Corp
PINK:SCYYF
|
$2.70 Million |
|
PT Mitra Pedagang Indonesia Tb
JK:MPIX
|
$2.70 Million |
|
T.R.V. Rubber Products PCL
BK:TRV
|
$2.70 Million |
|
Olivut Resources Ltd
PINK:OLVRF
|
$2.70 Million |
|
Searefico Corp
VN:SRF
|
$2.70 Million |
|
Etruscus Resources Corp
PINK:ETRUF
|
$2.70 Million |
|
INNELEC MULT.IMMINHEO153
F:1W2
|
$2.70 Million |
|
Compodium International AB
ST:COMPDM
|
$2.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JUVA LIFE INC.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares JUVA LIFE INC.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently JUVA LIFE INC. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares JUVA LIFE INC.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JUVA LIFE INC. (4VV) | €- | N/A | N/A | $2.70 Million |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |